1-4 of 4
Authors: Xiaodong Li
Sort by
Journal Article
Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis Free
Xiaodong Li and others
Endocrinology, Volume 159, Issue 1, January 2018, Pages 260–271, https://doi.org/10.1210/en.2017-00794
Published: 20 October 2017
Journal Article
Progressive Increases in Bone Mass and Bone Strength in an Ovariectomized Rat Model of Osteoporosis After 26 Weeks of Treatment With a Sclerostin Antibody
Get access
Xiaodong Li and others
Endocrinology, Volume 155, Issue 12, 1 December 2014, Pages 4785–4797, https://doi.org/10.1210/en.2013-1905
Published: 01 December 2014
Journal Article
Increased Bone Formation and Bone Mass Induced by Sclerostin Antibody Is Not Affected by Pretreatment or Cotreatment with Alendronate in Osteopenic, Ovariectomized Rats
Get access
Xiaodong Li and others
Endocrinology, Volume 152, Issue 9, 1 September 2011, Pages 3312–3322, https://doi.org/10.1210/en.2011-0252
Published: 01 September 2011
Journal Article
Knockout of the Murine Prostaglandin EP2 Receptor Impairs Osteoclastogenesis in Vitro
Get access
Xiaodong Li and others
Endocrinology, Volume 141, Issue 6, June 2000, Pages 2054–2061, https://doi.org/10.1210/endo.141.6.7518
Published: 01 June 2000
Advertisement
Advertisement